ZA919769B - Oral administration of alpha intereron to treat lung malignancies - Google Patents

Oral administration of alpha intereron to treat lung malignancies

Info

Publication number
ZA919769B
ZA919769B ZA919769A ZA919769A ZA919769B ZA 919769 B ZA919769 B ZA 919769B ZA 919769 A ZA919769 A ZA 919769A ZA 919769 A ZA919769 A ZA 919769A ZA 919769 B ZA919769 B ZA 919769B
Authority
ZA
South Africa
Prior art keywords
intereron
alpha
oral administration
treat lung
lung malignancies
Prior art date
Application number
ZA919769A
Inventor
Robert J Spiegel
J Spiegel Robert
Francis M Cuss
M Cuss Francis
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of ZA919769B publication Critical patent/ZA919769B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
ZA919769A 1990-12-14 1991-12-11 Oral administration of alpha intereron to treat lung malignancies ZA919769B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US62824090A 1990-12-14 1990-12-14

Publications (1)

Publication Number Publication Date
ZA919769B true ZA919769B (en) 1992-09-30

Family

ID=24518070

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA919769A ZA919769B (en) 1990-12-14 1991-12-11 Oral administration of alpha intereron to treat lung malignancies

Country Status (11)

Country Link
EP (1) EP0563177A1 (en)
JP (1) JPH06503570A (en)
AU (1) AU9139091A (en)
CA (1) CA2098393A1 (en)
EE (1) EE9400337A (en)
IE (1) IE914326A1 (en)
IL (1) IL100332A0 (en)
MX (1) MX9102512A (en)
PT (1) PT99784A (en)
WO (1) WO1992010207A1 (en)
ZA (1) ZA919769B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9213322D0 (en) * 1992-06-23 1992-08-05 Efamol Holdings Antioxidant compositions
EP1104809A1 (en) * 1994-04-09 2001-06-06 F. Hoffmann-La Roche Ag Process for producing alpha-interferon
US6207145B1 (en) 1997-05-09 2001-03-27 Pharma Pacific Pty Ltd. Therapeutic applications of high dose interferon
CN1151840C (en) * 1996-05-09 2004-06-02 太平洋制药控股公司 Stimulation of host defence mechanisms against tumors
CA2253971A1 (en) 1996-05-09 1997-11-13 Pharma Pacific Pty.Ltd. Use of high dose interferon by oralmucosal contact to treat viral infections and neoplastic conditions
AUPN976596A0 (en) * 1996-05-09 1996-05-30 Pharma Pacific Pty Ltd Stimulation of host defence mechanisms
US6660258B1 (en) 1997-05-09 2003-12-09 Pharma Pacific Pty Ltd Oromucosal cytokine compositions and uses thereof
AU2002330801A1 (en) * 2002-06-20 2004-01-06 Igor Anatolievich Pomytkin Method for oral transmucosal delivery of interferon

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0305551A3 (en) * 1981-10-13 1990-01-10 Exovir, Inc. Pharmaceutical compositions for topical application
ZA899113B (en) * 1988-12-01 1990-08-29 Schering Corp Treatment of squamous cell carcinoma intralesionally with recombinant human alpha interferon

Also Published As

Publication number Publication date
EE9400337A (en) 1996-02-15
JPH06503570A (en) 1994-04-21
PT99784A (en) 1992-12-31
WO1992010207A1 (en) 1992-06-25
MX9102512A (en) 1992-06-01
CA2098393A1 (en) 1992-06-15
AU9139091A (en) 1992-07-08
IE914326A1 (en) 1992-06-17
IL100332A0 (en) 1992-09-06
EP0563177A1 (en) 1993-10-06

Similar Documents

Publication Publication Date Title
GB2231265B (en) Therapeutic use of serotonin-antagonists
PH22677A (en) Treatment of oral diseases
GB8618466D0 (en) Administering medicaments to patients
EP0202051A3 (en) Therapeutic compositions for oral administration
GB8326878D0 (en) Administering medicaments to patients
GB8602264D0 (en) Administering medicaments to patients
IT9022471A0 (en) PROCEDURE AND EQUIPMENT FOR THE UNIQUE COMBINATION OF DRUGS CORRESPONDING TO A THERAPY DESCRIBED FOR A SPECIFIC PATIENT
GB2176584B (en) Improvements relating to the treatment of tobacco
AU8910891A (en) Treatment of lung diseases
ZA931489B (en) Use of interleuken-10 to suppress graft-vs-host disease
ZA919769B (en) Oral administration of alpha intereron to treat lung malignancies
GB2162748B (en) Medicinal composition for the treatment or prevention of acne by oral administration
EP0249165A3 (en) Medicine for combating malignant and chronic diseases
GB2190000B (en) Inhalation therapy unit
GB9122609D0 (en) Improvements relating to the treatment of haemophilia
HU9301453D0 (en) Nucleinic acide derivatives of anesthetic effect
GB2220652B (en) Treatment of pastures
GB9025154D0 (en) Treatment of lung diseases
IL100415A0 (en) Administering alpha interferon by oral inhalation to treat asthma and non-malignant proliferative pulmonary diseases
GB8819626D0 (en) Pharmaceutical composition for treatment of tumours
IT9021051A0 (en) "PROCEDURE FOR EXTRACTION AND PURIFICATION OF RECOMBITE HUMAN INTERFERON GAMMA"
IE861386L (en) Treatment of oral diseases
SG135193G (en) Therapeutic use of serotonin-antagonists
ZA875652B (en) Therapeutic use of serotonin-antagonists
ZA919959B (en) Administering alpha interferon by oral inhalation to treat asthma and non-malignant proliferative pulmonary diseases